Process for producing radiolabelled benzodiazepine receptor agents and composition containing the same
AssigneeMap Medical Technologies Oy
InventorsChristian Foged, Christer Halldin, Jukka Hiltunen, Lars Farde
Life of this patent
Estimating the term…
Abstract
A process for producing a carrier free radio halogenated 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5,6-dihydro-5-methyl-6-oxo-4H-imida zo[1,5-a][1,4]-benzodiazepine of formula (II) where R.sup.1 is a radioactive halogen and R.sup.1 may be at 7, 8, 9 or 10 substituent. The above compound is used in a pharmaceutical composition for nuclear medicine examination.
Claims18
A process for producing a radiohalogenated 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5,6-dihydro-5-methyl-6-oxo-4H-imida zo[1,5-a][1,4]-benzodiazepine wherein a precursor of the general formula (I) ##STR3## wherein R is bromine or iodine and R is a 7, 8, 9, or 10 substituent, is converted into a radiohalogenated 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5,6-dihydro-5-methyl-6-oxo-4H-imida zo[1,5-a][1,4]-benzodiazepine of the general formula ##STR4## wherein R.sup.1 is a radioactive halogen, selected from radioactive iodine, radioactive bromine, radioactive fluorine and R is a 7, 8, 9 or 10 substituent, by performing a radiohalogenization reaction comprising exchanging the inactive halogen of the precursor (I) into a radioactive halogen at an elevated temperature in a halogen-free acidic medium. whereafter the end product (II) is separated from the precursor (I) by using chromatographic methods.
A process for producing a radiohalogenated compound (II) according to claim I wherein said temperature is 100.degree. C. to 250.degree. C.
Dependencies are inferred from the claim text.